Parvovirus B19-induced Severe Anemia in Heart Transplant Recipients: Case Report and Review of the Literature

Overview

Journal Clin Transplant

Specialty General Surgery

Date 2019 Feb 19

PMID 30776137

Citations 5

Authors

Natalia C Pinto

Clarissa Newman

Carlos A Gomez

Kiran K Khush

Yasbanoo Moayedi

Roy Lee

Jeffrey J Teuteberg

Jose G Montoya

Affiliations

Soon will be listed here.

Abstract

We report a case of a 64-year-old woman who developed transfusion-dependent anemia after cardiac transplantation, the etiology of which was unknown after initial comprehensive evaluation. At the suggestion of the Transplant Infectious Diseases consultant, microbial agents with red blood cell tropism pertinent to this patient such as Parvovirus B 19 (B19V) were investigated. The B19V viral load by PCR in peripheral blood was >100 000 000 copies/ml and after treatment with intravenous immunoglobulin (IVIG), her anemia resolved. Here, we summarize the clinical and virologic characteristics, treatment, and outcome of fifteen cases of B19V-induced anemia in heart transplant recipients. Spontaneous recovery from anemia secondary to B19V has also been reported in some heart transplant recipients, possibly due to an absence of their B19V P-antigen receptor and/or reduction in their immunosuppression. Therefore, in heart transplant patients, B19V should be suspected early as a cause of severe anemia of unknown etiology. The extent that B19V-induced anemia is underdiagnosed in heart transplant recipients is unknown.

Citing Articles

Predictive performance of Metagenomic Next Generation Sequencing in early detection of post-liver transplantation infections.

Zhuang L, Zhu C, Ma J, Zhu D, Zhu H, Zhong S Heliyon. 2024; 10(16):e36405.

PMID: 39253237 PMC: 11381781. DOI: 10.1016/j.heliyon.2024.e36405.

A Case with Iron Deficiency Anemia Developed Aplastic Crisis.

Iketani K, Minamikawa S, Sakata M, Ishida Y, Nakagishi Y Kobe J Med Sci. 2023; 68(1):E1-E4.

PMID: 36647080 PMC: 10117628.

Structures and implications of the nuclease domain of human parvovirus B19 NS1 protein.

Zhang Y, Shao Z, Gao Y, Fan B, Yang J, Chen X Comput Struct Biotechnol J. 2022; 20:4645-4655.

PMID: 36090819 PMC: 9440244. DOI: 10.1016/j.csbj.2022.08.047.

Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.

Zanella M, Cordey S, Kaiser L Clin Microbiol Rev. 2020; 33(4).

PMID: 32847820 PMC: 7462738. DOI: 10.1128/CMR.00027-20.

Parvovirus B19-induced severe anemia in heart transplant recipients: Case report and review of the literature.

Pinto N, Newman C, Gomez C, Khush K, Moayedi Y, Lee R Clin Transplant. 2019; 33(4):e13498.

PMID: 30776137 PMC: 6850585. DOI: 10.1111/ctr.13498.

References

Thio K, Janner D . Aplastic anemia in a cardiac transplant recipient. Pediatr Infect Dis J. 1996; 15(12):1139, 1141-2. DOI: 10.1097/00006454-199612000-00022. View

Weigel-Kelley K, Yoder M, Chen L, Srivastava A . Role of integrin cross-regulation in parvovirus B19 targeting. Hum Gene Ther. 2006; 17(9):909-20. DOI: 10.1089/hum.2006.17.909. View

Shao E, Wang C, Javorsky G . Parvovirus B19 Induced Red Cell Aplasia in a Heart Transplant Patient Diagnosed on Pleural Fluid. Transplantation. 2018; 102(8):e367-e368. DOI: 10.1097/TP.0000000000002277. View

Bisognano J, Morgan M, Lowes B, Wolfel E, Lindenfeld J, Zisman L . Acute parvovirus infection in a heart transplant recipient. Transplant Proc. 1999; 31(5):2159-60. DOI: 10.1016/s0041-1345(99)00293-6. View

Kelleher E, McMahon C, McMahon C . A case of parvovirus B19-induced pure red cell aplasia in a child following heart transplant. Cardiol Young. 2014; 25(2):373-5. DOI: 10.1017/S1047951114000225. View

Brown K, Hibbs J, Gallinella G, Anderson S, Lehman E, McCarthy P . Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med. 1994; 330(17):1192-6. DOI: 10.1056/NEJM199404283301704. View

Fong C, Kaplan Z . Parvovirus B19–induced pure red cell aplasia in a heart transplant recipient. Blood. 2012; 120(17):3395. DOI: 10.1182/blood-2012-06-435230. View

Lower F, Menon S, Sanchez J . Association of parvovirus B19 with plasma cell-rich myocardial infiltrates after heart transplantation. J Heart Lung Transplant. 2001; 20(7):755-8. DOI: 10.1016/s1053-2498(01)00233-9. View

Pinto N, Newman C, Gomez C, Khush K, Moayedi Y, Lee R . Parvovirus B19-induced severe anemia in heart transplant recipients: Case report and review of the literature. Clin Transplant. 2019; 33(4):e13498. PMC: 6850585. DOI: 10.1111/ctr.13498. View

10.

Amiot L, Langanay T, Drenou B, Lelong B, Le Prise P, LOGEAIS Y . Spontaneous recovery from severe parvovirus B19 pure red cell aplasia, in a heart transplant recipient, as demonstrated by marrow culture. Hematol Cell Ther. 1998; 40(2):71-3. View

11.

WICKI J, Samii K, Cassinotti P, Voegeli J, Rochat T, Beris P . Parvovirus [correction of Parovirus] B19-induced red cell aplasia in solid-organ transplant recipients. Two case reports and review of the literature. Hematol Cell Ther. 1997; 39(4):199-204. DOI: 10.1007/s00282-997-0199-9. View

12.

Ozawa K, Kurtzman G, Young N . Replication of the B19 parvovirus in human bone marrow cell cultures. Science. 1986; 233(4766):883-6. DOI: 10.1126/science.3738514. View

13.

Sadigh S, Frank D . Red cheeks to red cell aplasia: parvovirus B19 in a heart transplant patient. Blood. 2017; 130(8):1071. DOI: 10.1182/blood-2017-05-785691. View

14.

Heegaard E, Brown K . Human parvovirus B19. Clin Microbiol Rev. 2002; 15(3):485-505. PMC: 118081. DOI: 10.1128/CMR.15.3.485-505.2002. View

15.

WEILAND H, Salimans M, Fibbe W, Kluin P, Cohen B . Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant patient. Br J Haematol. 1989; 71(2):300. DOI: 10.1111/j.1365-2141.1989.tb04276.x. View

16.

Cursack G, Crespo-Leiro M, Paniagua-Martin M, Muniz J, Naya C, Grille Z . [Chronic anemia in heart transplant patients: prevalence, predisposing factors and prognostic significance]. Rev Esp Cardiol. 2007; 60(11):1144-50. View

17.

Hullin R . Heart transplantation: current practice and outlook to the future. Swiss Med Wkly. 2014; 144:w13977. DOI: 10.4414/smw.2014.13977. View

18.

Weigel-Kelley K, Yoder M, Srivastava A . Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells. J Virol. 2001; 75(9):4110-6. PMC: 114156. DOI: 10.1128/JVI.75.9.4110-4116.2001. View

19.

Munakata Y, Saito-Ito T, Kumura-Ishii K, Huang J, Kodera T, Ishii T . Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood. 2005; 106(10):3449-56. DOI: 10.1182/blood-2005-02-0536. View

20.

Bergen G, Sakalosky P, Sinnott J . Transient aplastic anemia caused by parvovirus B19 infection in a heart transplant recipient. J Heart Lung Transplant. 1996; 15(8):843-5. View